Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection

US Patent 7879815 · Granted Feb 1, 2011

Estimated economic value: $44,131,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oxazolidinone compounds and methods of use thereof as antibacterial agents2025
Antimalarial agents2025
Antimalarial agents2025
Fused pentacyclic imidazole derivatives2024
Bicyclic peptide ligands specific for TSLP2024
Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as C2023
N3-substituted iminopyrimidinones as antimalarial agents2023
Antimalarial hexahydropyrimidine analogues2022
Compounds2022
Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors2021
Aminopyrimidine compound2021
Alkoxy bis-heteroaryl derivatives as modulators of protein aggregation2021